Norges Bank Kezar Life Sciences, Inc. Transaction History

Norges Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$12.3 - $18.33 $6.05 Million - $9.01 Million	491,500 New	491,500 $8.17 Million
Q1 2022 May 09, 2022	SELL	$12.3 - $18.33 $6.05 Million - $9.01 Million	-491,500 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$7.44 - $16.72 $3.66 Million - $8.22 Million	491,500 New	491,500 $8.22 Million
Q3 2018 Nov 09, 2018	SELL	$15.5 - $21.41 $77,500 - $107,050	-5,000 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$17.15 - $17.79 $85,750 - $88,950	5,000 New	5,000 $86,000

1.54M

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $438M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.